Delivery Order HHSD200201253663I-75D30121F00021
Award Date
1/1/21
Potential Completion Date
9/29/24
Potential Value
$1.3M
Federal Agency
CDC Pittsburgh
Awardee
Duke University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27708, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Duke University by the Centers for Disease Control and Prevention (CDC) under the Clinical Immunization Safety Assessment (CISA) indefinite delivery indefinite quantity (IDIQ) vehicle. The $1,738,484.00 delivery order is for the CISA COVID MATERNAL STUDY, which will be performed in Durham, NC. The contract does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award. The contract...
The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
This is a federal contract award to Duke University, a leading research institution, by the Centers for Disease Control and Prevention (CDC). The contract, valued at $1,893,456.00, is for the provision of COVID-19 clinical immunization safety assessment (CISA) services in Cincinnati. The contract is a delivery order issued under the CISA indefinite delivery, indefinite quantity (IDIQ) contract vehicle, which enables the CDC to obtain these critical services. The contract does not have a...
Duke University Office of Research Administration Division was awarded a cost-no-fee delivery order against a Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC). The $8.3 million delivery order is to support pediatric trials conducted by the National Institutes of Health's National Institute of Child Health and Human Development. As the prime contractor, Duke University will provide...
This contract was awarded to Duke University by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) as a delivery order against the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) IDIQ contract. The contract has a firm fixed price of $1,947,688.74 and a completion date of May 31, 2022. It is not set aside for any socioeconomic program. As the prime contractor, Duke University is providing clinical research and...
Duke University's Office of Research Administration Division was awarded a cost-no-fee delivery order contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide Clinical Immunization Safety Assessment (CISA) services. This order, valued at $1,068,872.10, will be performed in Durham, North Carolina through September 2022. The contract is part of a larger IDIQ vehicle with a potential value of $86 million through September 2028. Duke University is...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University, a private university and non-profit organization, to provide clinical research and immunization safety assessment services. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $465,451.00 and was awarded on September 29, 2015, with a completion date...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $608,717 delivery order contract to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The contract has a period of performance ending on September 30, 2020 and is not associated with a set-aside. This delivery order is part of a larger CISA indefinite delivery, indefinite quantity (IDIQ) contract with a...
Duke University was awarded a $2,031,493.71 firm fixed price contract by the Centers for Disease Control and Prevention (CDC) to support Topic 2 of the FY 2020 COVID-19 Broad Agency Announcement. Performance will take place in Atlanta, GA through December 31, 2022. As prime contractor, Duke University will provide clinical research and immunization safety assessment services to the CDC under this award. The Institute for Medical Research, Inc., a nonprofit research organization supporting work...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University to provide clinical research and immunization safety assessment services under the indefinite delivery indefinite quantity (IDIQ) Clinical Immunization Safety Assessment (CISA) contract vehicle. The award has a ceiling value of $549,433.00 and the period of performance runs through September 29, 2020. The contract does not have a set-aside designation. As a prime contractor for the...